Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 30 - 14.
International AffairsAdvanced technology and technological innovationsAsiaChinaData collection, sharing, protectionEuropeGeneticsIntellectual propertyIranLicensing and registrationsMiddle EastNorth KoreaRussiaTrade restrictionsTrade secrets and economic espionage
Why This Matters
This bill aims to protect U.S. synthetic biology by requiring licenses for exporting certain DNA and RNA sequences. It addresses concerns about foreign countries potentially stealing sensitive biological information.
If you work in biotechnology, you will need to navigate new export licensing requirements for certain genetic information.
Who this affects
Biotechnology companies · Researchers in synthetic biology
What changes is this bill making?
1This bill requires a license to export certain synthetic DNA and RNA sequences.
2It aims to prevent foreign entities from accessing sensitive U.S. biological information.
3The bill targets countries considered a threat to U.S. national security.
4It focuses on controlling digital sequences created by humans or artificial intelligence.
5The bill is part of efforts to protect U.S. intellectual property in biotechnology.